Clinical trial
EXTEND Protocol for Transplanted Patient to Evaluate Kidney Function
NCT00302497 · McGill University Health Centre/Research Institute of the McGill University Health Centre, Other · Unknown status
Key facts
| NCT number | NCT00302497 |
|---|---|
| Title | EXTEND Protocol for Transplanted Patient to Evaluate Kidney Function |
| Official title | 12 Month, Prospective, Randomised, Open-Label Comparative Study to Evaluate the Protection of Kidney Function by Basiliximab in a CNI-Free Regimen in Newly Kidney Transplanted Patients (Three Months Post-Transplant) Who Are Recipient of One Kidney From Expanded Donor Criteria (UNOS Criteria) |
| Lead sponsor | McGill University Health Centre/Research Institute of the McGill University Health Centre, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Kidney Transplant |
| Intervention type | Drug |
| Interventions | basiliximab |
| Enrollment | 50 |
| Start date | Apr 1, 2007 |
| Completion | Apr 1, 2008 |
| First posted | Mar 14, 2006 |
| Last update posted | Apr 12, 2007 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: